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Anthelmintic treatment increases the Mycobacterium tuberculosis-specific 
CD4+ T-cell response, associated with a decrease of FoxP3+ regulatory T cells 
in migrants with latent TB infection in London.[LS1] 
Mycobacterium tuberculosis-specific CD4+ T-cell reponse is reduced, and reg-
ulatory T cells are increased in TB patients after anthelminthic treatment 
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Abstract: 
XXX. [LS4]To We investigated the potential impact of helminth infection on immune responses to 
Mycobacterium tuberculosis (Mtb) we recruited in patients with latent Mtb infection (LTBI) with 
or without helminth infection (Strongyloides or Schistosoma), and tested T T-cell [LS5]responses 
before and after anthelminthic treatment. The study was performed in migrants resident in the 
UK, where re-exposure and re-infection following anthelminthic treatment would not occur. The 
frequency of CD4+IFN-γ+ T cells was measured following stimulation with Mtb PPD or 
ESAT-6/CFP-10 antigen, and concentrations of IFN-γ in culture supernatants measured by 
ELISA and multiplex bead array. Helminth infection was associated with a lower frequency of 
CD4+IFNγIFN-γ+ T cells, which increased following treatment. Patients with helminth infection 
showed a significant increase in CD4+FoxP3+ T (Treg) cells [LS6]compared to those without hel-
minth infection. Following anthelminthic treatment thThere was a decrease in the frequency of 
CD4+FoxP3Treg+ cells, and an associated increase in CD4+IFNγIFN-γ+ T cells after the anthel-
minthic treatment. This study thereforeHere, we shows the a potential role of regulatory 
CD4+FoxP3+ Treg cells in reducing the frequency and function of anti-mycobacterial 
CD4+IFNγIFN-γ+ T cells, and that  these effects the reversal ofare reversed after these effects 
following anthelminthic treatment, in a setting where re-infection would not occur.[LS7] 
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Introduction: 
Mycobacterium tuberculosis (Mtb) infects a third of the world’s population, causing 1.5 million 
deaths a year [1, 2]. In addition, helminth infections are estimated to affect 1.5 billion people 
worldwide, with the majority of these infections concentrated in developing countries where TB 
is endemic [3, 4].  
Helminth infections are reported to induce Th2 type immune responses in the host [5], and evi-
dence suggests that Th2 cytokines may play a critical role in reducing the Th1 immune response 
to other infections. Protection against tuberculosis is not well understood, but Th1 T cell re-
sponses involving interferon gamma (IFNγIFN-γ), tumour necrosis factor alpha (TNFα), and 
interleukin 2 (IL-2) are induced in the immune response to Mtb [6]. IFNγIFN-γ is thought to play 
an important role in the protective immune response against tuberculosis (TB) as indicated by the 
susceptibility of humans with IFNγIFN-γ signalling pathway deficiencies to TB disease [7, 8]. A 
number of studies have previously investigated the immunomodulatory effect of helminth infec-
tion on anti-mycobacterial immunity (reviewed in [9]). For example, in mouse models it has 
been shown that helminth infection can inhibit the immune response to Mtb [10]. A study per-
formed in Ethiopia has shown an impact of deworming on the immune response to Mtb Purified 
Protein Derivative (PPD) [11]. As helminths have been shown to modulate immunity towards 
Th2 type responses, this may make individuals infected with helminths more susceptible to pro-
gression of tuberculosis infection [11-16]. 
Regulatory T cells (Treg), are another way to control and regulate immune responses. These cells 
are able to control both Th2 and Th1 type immune responses [17]. Helminth infection can in-
crease the frequency of Treg cells in mice [18, 19], and in man an increase of Treg cells has been 
observed in Strongyloides infection in patients co-infected with HTLV-1 [20] as well as in 
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hookworm infected patients [21]. Furthermore it has been shown that Treg cells can modulate 
the immune response in BCG vaccinated individuals [22, 23] and in patients with active tuber-
culosis [24]. A recent study showed that in children in Gabon, the proportion of Tregs decreased 
with anthelminthic treatment [25].  
 
There have been only a few studies that investigated the impact of helminth infections on T cell 
immunity in patients with latent TB infection. Filaria infections were shown to reduce Th1 re-
sponses in Indian patients with LTBI, that were increased with blockage of CTLA-4 or PD-1 
[26], while anthelminth treatment increased TLR2 and TLR9 expression with an associated in-
crease in production of pro-inflammatory cytokines. In Indian patients with LTBI, coincident 
hookworm infection reduced Mtb-specific Th1 and Th17 CD4 T cells [14]. Indian pulmonary 
tuberculosis patients with Wucheria or Stronglyoides also showed reduced CD4 and CD8 T cells 
responses to mycobacterial antigens, that could be partly blocked with anti-IL-10 neutralising 
antibodies [27]. 
In this study we measured the impact of anthelmintic treatment on the immune response to Mtb 
in LTBI in a migrant cohort in London. As the UK is not ana helminth endemic area, reinfection 
is not likely in this setting. This provides a unique opportunity to study the effect of anthelminth 
treatment on the immune response in helminth infected patients. We also measured the frequency 
of CD4+FoxP3+ Treg cells in order to assess the potential impact of Treg cells in helminth in-
fected patients. [LS8]FoxP3 is currently the best known single marker of the major population of 
Treg cells [17, 28, 29] and previous studies have shown that assessing CD4+FoxP3+ T cells is a 
convenient way to measure the Treg-cell population in human PBMCs [30, 31]. The results ob-
tained in this study demonstrate the influence of helminths in reducing the immune responses to 
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Mtb, and the importance that CD4+FoxP3+ T cells play in this modulation.
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Results 
Impact of helminth infection on T cell responses to Mtb. 
We measured the frequency of CD4+IFNγIFN-γ+ T cells in PBMCs from uninfected individuals, 
helminth infected patients, LTBI individuals and patients co-infected with helminths and LTBI 
(Figure 1). The results show a significant reduction of the frequency of CD4+IFNγIFN-γ+ T cells 
in helminth infected versus non helminth infected individuals after stimulation of cells with PPD 
(Figure 1A). The reduction is even more significant (p=0.001) in the group with LTBI. There 
was no difference in frequency of CD4+IFNγIFN-γ+ T cells between the helminth only vs. the 
helminth+LTBI group. We did not observe any significant difference in responses between 
Strongyloides and Shistosomiasis infected patients (data not shown). PBMC were also stimulated 
with the M.tuberculosis fusion protein ESAT-6/CFP10, peptides from which form the basis of 
the QuantiFeron Gold InTube (QFT-GIT) test. The results show that, as observed with PPD 
stimulation, helminth infected patients have a significant reduction in the frequency of 
CD4+IFNγIFN-γ+ T cells (Figure 1B). As controls, patients with negative QFT-GIT were also 
tested but did not respond to ESAT-6/CFP10 (data not shown). Furthermore, we did not observe 
any significant expression of IFNγIFN-γ in the CD8+ population after stimulation with PPD or 
ESAT-6/CFP10. 
 
Anthelmintic treatment increases the frequency of CD4+IFNγIFN-γ+ T cells after stimula-
tion. 
Patients were requested to come back at least 4 months after receiving anthelmintic treatment 
(V2). We stimulated PBMC from these treated patients using the same protocol as used for cells 
from the first clinic visit prior to treatment (V1). The results show that anthelmintic treatment 
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induces a significant increase in the frequency of CD4+IFNγIFN-γ+ T cells after stimulation with 
PPD (Figure 2A) or ESAT-6/CFP10 (Figure 2B), in both the helminth (p=0.001) and the hel-
minth+LTBI (p=0.001 for PPD and p=0.002 for ESAT-6/CFP10) groups, compared to the same 
groups before treatment. The control group and the LTBI group were also analysed at least 4 
months after the initial visit, but without receiving any anthelmintic treatment. In these groups 
we did not observe any significant modifications of the frequency of CD4+IFNγIFN-γ+ T cells 
after stimulation by PPD or ESAT-6/CFP10 compared to the initial test results. 
 
Increased frequency of CD4+FoxP3+ T cells in helminth infected patients. 
We next analysed the frequency of CD4+FoxP3+ T cells in cells after overnight incubation, 
without any stimulation as described in earlier studies [30, 31]. The results show that helminth 
infected patients have a significantly higher proportions of CD4+FoxP3+ T cells compared to the 
non-helminth-infected control group (p=0.0001) (Figure 3). Furthermore, helminth-LTBI 
co-infected patients had significantly higher proportions of CD4+FoxP3+ T cells compared to the 
LTBI group (p=0.0001). However, there were no significant differences in the frequency of 
CD4+FoxP3+ T cells between the control and LTBI groups (p=0.124), or between the helminth 
infected and helminth-LTBI groups (p=0.87). 
 
The frequency of CD4+FoxP3+ T cells is decreased after anthelmintic treatment in helminth 
infected patients.[LS9] 
 The patients were requested to return for a follow up visit more than 4 months after taking an-
thelmintic treatment. The frequencies of CD4+FoxP3+ T cells were analysed after overnight in-
cubation, without any stimulation as previously described [30]. The frequencies of CD4+FoxP3+ 
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T cells after treatment were compared to the frequencies measured in the same patients before 
treatment (V1). The results in Figure 4 show the frequency of CD4+FoxP3+ cells, measured in 
patients before treatment (V1) compared with the frequency in the same patients at least 4 
months after treatment (V2). Helminth infected patients showed a significant decrease in the 
frequency of CD4+FoxP3+ T cells after anthelmintic treatment (p=0.0001 for the helminth group 
and p=0.002 for the LTBI-helminth group, compared respectively to the control group and to the 
LTBI group). However, there were no such differences in the frequencies of CD4+FoxP3+ T cells 
between the control and LTBI groups. There were no significant differences in the frequency of 
CD4+FoxP3+ T cells between the helminth and the LTBI+helminth groups after treatment. 
 
Depletion of CD4+CD25+ T cells reduces CD4+FoxP3+ T cell frequency and increases the 
frequency of CD4+INFγ+ T cells induced by PPD stimulation, in helminth infected pa-
tients.[LS10] 
To test the importance of CD4+FoxP3+ T cells in regulation of mycobacterial antigen-specific T 
cell responses, we depleted the CD25+ cells from six untreated helminth infected patients. The 
representation of 2 typical experiments are illustrated in Figure 5A. The pooled result (Figure 
5B) shows that in PBMC from the 6 patients, after depletion of the CD25+ T cells, there was a 
significant decrease in the frequency of CD4+FoxP3+ T cells. We next measured, as described 
above, the response of the PBMC after stimulation with PPD. In all six patients there was an 
increase in the frequency of CD4+IFNγIFN-γ+ T cells after stimulation with PPD in the CD25+ 
depleted PBMC compared to the control PBMC. After depletion of CD25+ cells the frequency of 
CD4+IFNγIFN-γ+ T cells increased from 0.179% to 0.391% for patient#1, from 0.152% to 
0.324% for patient#2, from 0.335% to 0.793% for patient#3, from 0.469% to 0.865% for pa-
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tient#4, from 0.147% to 0.512% for patient#5 and from 1.43% to 2.37% for patient#6. The re-
sults in Figure 5B, show for each patient’s PBMC stimulated with PPD, there was an increase in 
the frequency of CD4+IFNγIFN-γ+ T cells associated with a decrease of CD4+FoxP3+ T cells. It 
is important to note that we also observed a small increase of CD4+IFNγIFN-γ+ T cells in the 
CD25 depleted fraction in non-stimulated control PBMC. Patient#6 showed a high frequency of 
CD4+IFNγIFN-γ+ T cells, but this patient was also latently infected with Mtb (LTBI). 
 
Anthelmintic treatment increases the secretion of IFNγIFN-γ in blood samples from hel-
minth infect patients after stimulation with PPD.[LS11] 
We stimulated fresh diluted whole blood from patients with control medium, PPD (10µg/ml) or 
ESAT-6/CFP10 (10µg/ml) for 1 day and 5 days and then collected supernatants for analysis us-
ing Luminex bead array technology. We compared the difference in responses between the first 
visit (V1) and the post treatment visit (V2). From the supernatant 12 cytokines were measured 
(IL-2, IL-4, IL-5, IL-10, IL-13, IL-17A, IL-17F, IL-21, IL-22, IFNγIFN-γ, IP10, TNFα). From 
day 1 supernatant analysis, we did not observe any significant secretion, or difference of expres-
sion between groups for all the cytokines measured (data not shown). At Day 5, only IFNγIFN-γ 
secretion showed significantly higher concentrations in the different groups after both PPD and 
ESAT6/CFP10 stimulation (Figure 6). The same patients were tested before anthelmintic treat-
ment and 4 months after this first visit. Stimulation with medium only gave <400pg/ml 
IFNγIFN-γ for each group (data not shown). Stimulation of cells from uninfected control and 
helminth patient groups with ESAT-6/CFP10 also gave negative responses of <400 pg/ml 
IFNγIFN-γ.  
The results shown in Figure 6 show that the secretion of IFNγIFN-γ after PPD stimulation is sig-
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nificantly lower (p=0.006) in the helminth infected patients compared to the control group. Fur-
thermore the secretion of IFNγIFN-γ, after stimulation with PPD, is significantly lower 
(p=0.017) in the co-infected Helminth+LTBI group of patients compared to the LTBI group. 
After anthelmintic treatment, retesting the same patients showed that there was a significant in-
crease in the production of IFNγIFN-γ in the helminth infected group; those infected with both 
helminths and LTBI showed an increase that was statistically significant (p=0.002). We also 
measured the secretion of IFNγIFN-γ after stimulation of the diluted blood with the Mtb fusion 
protein ESAT-6/CFP10. The results in Figure 6B show that before anthelmintic treatment, the 
IFNγIFN-γ concentrations measured were significantly lower in the co-infected helminth-LTBI 
group than in the LTBI group. After anthelmintic treatment, the same patients were re-tested in 
the same way, revealing a significant increase in IFNγIFN-γ concentrations (p=0.038).  
For the other cytokines measured, IL-4 and IL-5 were not detected in the supernatants collected 
at either day 1 or day 5. Other cytokines showed a very low level of secretion at day 1, with less 
than 10pg/ml for IL-13, less than 20pg/ml for IL-17A and IL-21 and less than 40pg/ml for IL-10 
and IL-13. No significant variations were observed between the groups with different conditions 
of stimulation (data not shown). On day 5 there was no significant variation in concentrations of 
IL-2 TNFα, IL-22, IL17F and IP10 between the groups and between samples tested post and 
pre-treatment. The results for these cytokines are presented on supplemental Figure 2 and Figure 
3. 
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Discussion 
Helminth infections are highly prevalent in populations where Mtb infection is endemic, and it 
has been widely conjectured that the strong mucosal Th2 and T regulatory cell responses elicited 
by these parasites could down-modulate protective immune responses against Mtb. Some studies 
have specifically demonstrated the importance of regulatory T cells in suppression of the im-
mune response to BCG during helminth infection [32, 33] and the modulation of the TB immune 
response during helminth infection [10, 14, 26]. A number of previous studies have investigated 
the immunomodulatory effect of helminth infections on anti-mycobacterial immunity [11, 34]. In 
this study we took advantage of an opportunity provided by a London cohort of immigrants who 
had presented with helminth infection with/without LTBI to evaluate the impact of deworming 
on the in vitro T cell memory response to Mtb in these patients. Our cohort gave us the ability to 
study these responses in a setting where the risk of re-exposure and re-infection was negligible, 
and so provided an ideal environment in which to study the impact of anthelmintic treatment on 
the anti-mycobacterial immune response. 
We compared groups of immigrants who presented with different diagnoses: infected by hel-
minths (mainly Strongyloides with a few Schistosome infections), infected by Mtb and diag-
nosed as LTBI (defined as Quantiferon IGRA test positive), co-infected with Mtb and helminths, 
or those uninfected with either helminths or Mtb. We first measured the immune response to 
Mtb, by measuring the frequency of CD4+IFN producing T cells in these different groups of 
patients after stimulation with PPD or ESAT-6/CF10. We observed that the helminth infected 
groups had lower responses to PPD and ESAT-6/CFP10 than those without diagnosed helminth 
infection. This suggests that the presence of helminths reduced the capacity of the PBMC to re-
spond to Mtb stimulation. This impact of worms on the TB immune response was recently shown 
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with hookworm infection, where the worm infection modulates the Th1 and Th17 response in 
patients with latent TB [14]. 
Following this first observation, we next compared the memory immune response to TB before 
anthelmintic treatment and after receiving treatment. Because these patients are resident in the 
UK, we do not expect reinfection with helminths during this period. Further clinical samples 
were tested after treatment, to confirm clearance of the helminth infections. We showed that an-
thelmintic treatment increased the memory immune response to Mtb (the helminth-LTBI group 
showed a significant increase in the frequency of CD4+IFNγIFN-γ+ T cells after treatment). We 
also stimulated PBMC from Mtb infected patients with the Mtb specific fusion protein 
ESAT-6/CFP10, and observed an increase in the frequency of CD4+IFNγIFN-γ+ T cells after 
anthelmintic treatment in the helminth-LTBI group only, but not in the non LTBI group, con-
firming the specificity of the ESA-T6/CFP10 antigen. 
We also carried out similar experiments by stimulating directly fresh diluted blood with either 
PPD or the Mtb fusion protein ESAT-6/CFP10, and by measuring the IFNγIFN-γ secretion after 
5 days of stimulation (Figure 6). We observed a similar result as had been observed with PBMC 
for helminth infected patients. The helminth infected group, or co-infected helminth-LTBI pa-
tients, secreted lower levels of IFNγIFN-γ after PPD stimulation than the non-helminth infected 
group or the LTBI group. Furthermore after ESAT-6/CFP10 stimulation we also observed lower 
IFNγIFN-γ secretion in the co-infected group with LTBI compared to the LTBI alone group. 
These results confirmed the observations made by flow cytometry. In the visit 2 group (V2), we 
only observed significant differences compared to pre-treatment in the helminth infected group 
when PBMC were stimulated with PPD. The helminth-LTBI group did not show a statistically 
significant difference in response on the first and second visits for either PPD or ESAT-6/CFP10 
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simulation. This result differs from the observation made by flow cytometry. Two hypotheses 
can explain why these results differ. First, in the flow cytometry experiments the stimulation 
with antigen is only overnight compared to the 5 day stimulation for the diluted whole blood 
assay. Secondly, we compared the PBMC response by flow cytometry rather than by diluted 
whole blood for the bead array assay. These two differences may explain the difference in re-
sponse to ESAT6/CFP10 stimulation. 
Helminth infections are largely associated with Th2 immune responses [5], and few studies have 
shown that helminth infection can be associated with an increase of regulatory T cells 
(Tregs)[18, 23, 25, 35, 36]. In this study we analysed the frequency of CD4+FoxP3+ T cells. As 
shown in a previous study of HTLV-1 infection, CD4+FoxP3+ T cells can be an excellent marker 
of regulatory T cell function [30, 37], as the CD25 activation marker may be modified by the 
infection [30, 38]. In our cohort we observed an increase of CD4+FoxP3+ T cells in the helminth 
infected groups, with both the helminth and helminth-LTBI groups showing an increase in the 
frequency of CD4+FoxP3+ T cells compared to the control group and the LTBI only groups. It is 
important to note that in our cohort we did not observe any difference in the frequency of 
CD4+FoxP3+ T cells between the control group and the LTBI group as has been shown in other 
studies [39, 40], although our control group had a frequency of CD4+FoxP3+ T cells close to the 
frequency measured in another study using PBMC cells [30]. 
We next compared the variation of the frequency of CD4+FoxP3+ T cells before and after an-
thelmintic treatment as we had for the Mtb specific T cell immune response. The results showed 
that anthelmintic treatment reduced the frequency of CD4+FoxP3+ T cells in the helminth infect-
ed and helminth-LTBI groups. There are very few reports showing an impact of anthelmintic 
treatment on the modulation of the frequency of CD4+FoxP3+ T cells, apart from a recent study 
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in which patients with Schistosomiasis in Gabon showed a marked reduction in the frequency of 
FOXP3+ T regs post treatment[25]. Interestingly, in our study after treatment the frequencies of 
CD4+FoxP3+ T cells measured in the helminth and helminth-LTBI groups were similar to the 
frequencies measured in the control group and the LTBI group. There was no significant varia-
tion in the frequency of CD4+FoxP3+ T cells in the control group or the LTBI group between the 
first visit (V1) and the follow-up visit (V2). Because we asked patients to return more than 4 
months after the anthelmintic treatment, we do not think the treatment itself has a direct impact 
on the frequency of CD4+FoxP3+ T cells measured, or on the other immune responses measured 
at V2. 
The question arises: what is the role of CD4+FoxP3+ T cells in helminth infection and what role 
does this population play in the inhibition of the memory immune response to Mtb? To answer 
this question we selected 6 helminth infected patients, to test if the CD4+FoxP3+ T cells were 
directly involved in the reduction in the frequency of CD4+IFNγIFN-γ+ T cells after stimulation 
with PPD. As FoxP3 is a nuclear marker, it cannot be used to purify or deplete FoxP3+ T cells, 
however CD25 is a surface marker, that can be used to purify or deplete CD4+FoxP3+ T cells 
[37]. We observed that when CD25+ cells were depleted, resulting in a reduction of 
CD4+FoxP3+ T cells, this was associated with an increase in the frequency of CD4+INFγ+ pro-
ducing T cells after stimulation with PPD. This result suggests that CD4+FoxP3+ T cells could be 
directly involved in reducing the memory immune response to Mtb, as described in this study, 
and confirms the earlier findings in a group of Chinese TB patients where depletion of 
CD4+CD25+ FoxP3+ regulatory T cells increased secretion of IFNγIFN-γ and IL-10 [24].  
It is difficult to evaluate if the CD4+FoxP3+ cells are specific for an antigen. In vitro observations 
suggest a nonspecific impact of CD4+FoxP3+ T cells on antigen-specific responses. For example 
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in Figure 6, the control unstimulated PBMC cultures also showed higher CD4+IFNγIFN-γ+ T cell 
frequencies in the FoxP3 depleted fractions than in the non-depleted cultures. Furthermore, some 
studies suggest that intracellular IFNγIFN-γ does not correlate with protection against Mtb infec-
tion [41, 42], although the measurement of IFNγIFN-γ still a relevant marker of the immune re-
sponse [7, 43, 44]. Tregs are thought to exert their function via a number of different mecha-
nisms including IL-10 and/or TGF-β production, IL-2 consumption, or cell-cell contact where 
inhibitory molecules such as CTLA-4 and PD-1 are key [45, 46]. In a study on the impact of 
FoxP3 T cells in the modulation of immune responses in LTBI patients [47], the authors ob-
served a specific restoration of immune response after depletion of FoxP3+ cells, but not after 
blockage of specific immune suppressor molecules such as CTLA-4. 
Finally, these results suggest an important role for CD4+FoxP3+ T cells in the control of the Mtb 
immune response induced by helminths. Although the majority of our patients were infected with 
Strongyloides, a subset was infected with Schistosomes. A recent study also showed an impact of 
Schistosoma mansoni infection in a mouse model, where Treg cells were shown to induce sup-
pression of allergic airway immune response [35]. More interestingly another recent study on 
human Schistosomiasis patients showed an increase of CD4+CD25+FoxP3+ T cells in these pa-
tients, and this high frequency of Treg cells was reduced after anthelmintic treatment [25]. In this 
study we only focused on the IFNγIFN-γ response in LTBI and did not have an opportunity to 
measure the impact of helminth infection and anthelmintic treatment on TB patients with active 
clinical disease. Furthermore, due to a lack of Strongyloides antigen, it was only possible to 
measure the Mtb specific immune response; further studies could assess the helminth-specific 
immune response, and the level of Th2 cytokines that could be induced by these infections. Fur-
ther studies are now needed to investigate the impact on these Treg responses on progression to 
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TB. Although a recent study in India failed to show any effect on the rate of progression to active 
TB associated with filaria or hookworm infections [48] reinfection with both helminths and 
M.tuberculosis would be common in this setting[49].   
The next question that now needs to be answered is to understand how helminths induce this 
population of CD4+FoxP3+ T cells. Some studies have already investigated the potential function 
of CTLA-4 and PD-1 [26, 47] in the immune response against Mtb, and some recent studies in 
the mouse show that helminths can control the FoxP3+ T cell population via ICOS stimulation 
[50]. It also remains to be investigated how CD4+FoxP3+ T cells inhibit the T cell mediated im-
mune response, and whether in LTBI patients co-infected with helminths this inhibition is Mtb 
specific or reflects a more general immunosuppression in the co-infected human host.  
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Materials and Methods 
Subjects.  
Peripheral venous blood samples, anti-coagulated with sodium heparin, were donated by subjects 
at the Hospital for Tropical Diseases in London, and at Spitalfields Primary Care Trust clinic in 
East London. The patients were included in the study after being diagnosed with a high eosino-
phil count, with a history of living in the tropics, older than 18 years and with or without un-
treated latent TB infection (LTBI) (see Table I). We excluded HIV-positive, immunocompro-
mised patients, and patients with previous treatment for helminths. All our patient were BCG 
vaccinated. 
Serum samples were analysed by a commercial ELISA for anti-Strongyloides antibodies (Bordi-
er, France) according to the manufacturer’s protocol which uses a variable cut-off based on a low 
positive serum. For anti-schistosome antibodies, we used an in-house assay (IgG antibodies to 
Schistosoma egg antigens with a standard cut-off of 0.26 OD at 490nm), using the standard clin-
ical diagnostic tests currently in use in the National Parasite Reference Laboratory of the UK, 
based at the Hospital for Tropical Diseases (HTD). Stool analysis was performed following for-
mol ether/ethyl acetate faecal concentration using a Midi Parasep faecal concentrator. Faeces 
samples were also cultured to detect Stronglyoides or hookworm using the charcoal culture 
method. Urine analysis was performed by observation of Schistosoma eggs in the deposit of a 
filtered terminal urine sample. The presence of ova and cysts in stool samples was used to ex-
clude other helminth infections and these patients were excluded from further study. Filaria se-
rology was performed if the patient was from West Africa or had clinical evidence of filarial 
infection, with further tests if filarial serology was positive; no filarial infections were diagnosed 
in the patients studied here. In our cohort 84% of patients presented with a Strongyloides infec-
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tion, 10% with Schistosomiasis and 4% with both helminth infections. All the patients were 
tested for M. tuberculosis infection, using the QuantiFeron-Gold In-Tube assay (QFT-GIT). Pa-
tients with clinical symptoms of tuberculosis were screened for TB disease and excluded from 
this study if active TB disease was diagnosed. None of the LTBI patients included in this study 
were on treatment for their LTBI. Ethical permission for the study was obtained from the Ethics 
Committee at the London School of Hygiene and Tropical Medicine (ref: 5870) and the NHS 
(ref: 11/H0713/12). All the patients gave informed consent. Patient were recruited on their first 
visit to the clinic (V1) when they received anthelmintic treatment if required, and were requested 
to come back at least 4 months later for a follow-up visit (V2). Those not treated for helminths 
were also asked to come back 4 months later. The time interval between V1 and V2 is included 
as  V1-V2 in Table 1. The rate of follow up at visit2 was 15% for control, 26% for Helminth, 
92% for LTBI, and 41% for Helminth+LTBI. 
 
 
Flow cytometry. PBMCs were isolated by density centrifugation on Histopaque (Sigma, UK) 
and cryopreserved until used. Cells were cultured in complete medium (RPMI-1640, 10% FCS, 
penicillin/streptomycin, L-glutamine) at 37oC in 5% CO2. One millions PBMC were stimulated 
for 4h with medium alone, PPD batch RT 50 (Statens Serum Institute, Copenhagen, at 10µg/ml) 
or with the fusion protein ESAT-6/CFP10 (kindly provided by Kees Franken, Dept. of Infectious 
Diseases, Leiden University Medical Centre at 10µg/ml) in a volume of 300µl. After 4h, 600µl 
of complete medium containing Golgi plug (1µl/ml) and anti-CD28 (1µg/ml) (BD Bioscience) 
were added and PBMCs incubated for 18h. The cells were then stained with live dead stain 
(Invitrogen) to measure the viability. The viability measured was more than 95% in the experi-
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mentsincluded here. We then surface-stained with monoclonal antibodies to CD3-APC-cy7, 
CD4-PerCP-Cy5.5 and CD8-Pacific Blue (BD Bioscience, UK). Cells were then fixed and per-
meabilized with a commercial kit (Insight Biotechnology, Wembley, UK), following the manu-
facturer’s protocol. Finally, cells were stained intracellularly with an anti-human FoxP3-PE an-
tibody (clone 236A/E7; Insight Biotechnology) in permeabilization buffer (Insight Biotechnolo-
gy) following the manufacturer’s protocol, or with anti-human IFNγIFN-γ-APC (BD Bioscience, 
UK). 
After staining, cells were analysed on a LSRII flow cytometer. One million events were routinely 
collected. Doublets were excluded and CD3+ viable lymphocytes were gated and from this gate 
CD4 and CD8 population were discriminated for further analysis using Flow Jo. The complete 
gating strategy is presented in Supplemental figure 1.  
 
Cytokine and chemokine quantification by Luminex. Fresh heparinised blood samples were 
diluted 1:4 in RPMI medium. The diluted blood was stimulated with medium only, PPD (at 
10µg/ml) or the fusion protein ESAT-6/CFP10 (at 10µg/ml). Supernatants were collected after 5 
days of stimulation. Using a Luminex multibead antibody kit (Biorad, UK), we quantified the 
concentration of 12 cytokines using two kits: a Th1/Th2 8 plex kit detecting IL-2, IL-4, IL-5, 
IL-10, IL-13, IFNγIFN-γ, IP10, TNFα, and a Th17 4 plex kit detecting IL-17A, IL-17F, IL-21 
and IL-22. 
 
Purification of CD25+ cells. CD4+CD25+ cells were purified with antibody-coupled magnetic 
microbeads following the manufacturer’s instructions (Miltenyi Biotec). 
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Statistical analysis. Non-parametric statistical tests were used, using SPSS software (v20). 
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Figure Titles and Legends:[LS12] 
 
Figure 1: Frequencies of CD4+IFNγIFN-γ+ T cells induced by PPD (A) or ESAT-6/CFP10 
(B), are reduced in helminth infected patients. 
(A) PBMCs from Control (n=19), Helminth (n=48), LTBI (n=34) and co-infected Hel-
minth-LTBI (n=17) patients were stimulated with PPD.  These boxplot graph represent the fre-
quencies of CD4+IFNγ+ cells in the CD4+ T cell population measured in PBMC after stimulation 
with PPD, from Control (n=19), Helminth (n=48), LTBI (n=34) and co-infected Helminth-LTBI 
(n=17) patients. (B) PBMCs from Control (n=6), Helminth (n=10), LTBI (n=31) and co-infected 
Helminth-LTBI (n=15) patients were stimulated with ESAT-6/CFP10. (A and B) The frequen-
cies of CD4+IFN-γ+ cells in the CD4+ T cell population in PBMCs was measured by XXX. 
[LS13]Boxplots show the median, 25th and the 75th percentile (boxes) and minimum and maxi-
mum values (whiskers).These [LS14]boxplot graph represent the frequency of CD4+IFNγ+ cells in 
the CD4+ T cell populations measured in PBMC after stimulation with ESAT-6/CFP10, from 
Control (n=6), Helminth (n=10), LTBI (n=31) and co-infected Helminth-LTBI (n=15) patients. 
Data shown are representative of XXXX independent experiments.  [LS15]P values were deter-
mined by a non-parametric Mann-Whitney test.  
 
Figure 2: Anthelmintic treatment increases the frequency of CD4+IFNγIFN-γ+ T cells in 
helminth infected patients 
These line graph represent the frequency of CD4+IFNγ+ cells in (A nad B) CD4+ cells after stim-
ulation with PPD (A) or ESAT-6/CFP10 (B) from Control (n=5), Helminth (n=13), LTBI (n=30) 
and co-infected Helminth-LTBI (n=10) patients were stimulated with (A) PPD or (B) 
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ESAT-6/CFP10. The frequency of CD4+IFN-γ+ cells was measured by xxxx.  [LS16]The value 
plot on the left was obtained from patients on the first visit (V1), the value plot on the right was 
obtained on the follow up visit (V2), either more than 4 months after visit one, or more than 4 
months after anthelmintic treatment. Each line representrepresents an individual. P values were 
determined by a non-parametric paired Wilcoxon test.  Data shown are representative of XXXX 
independent experiments. [LS17] 
 
 
Figure 3: The frequency of CD4+FoxP3+ T cells is increased in helminth infected patients 
The box plots represent the frequency of CD4+FoxP3+ cells in the CD4+ T cell population, 
measured in PBMC incubated for 18h without stimulation PBMCs from Control (n=20), Hel-
minth (n=51), LTBI (n=34) and co-infected Helminth-LTBI (n=17) patients were incubated for 
18h without stimulation. The frequency of CD4+FoxP3+ cells in the CD4+ T cell population in 
PBMCswas measured by XXXX.  [LS18]Boxplots show the median, 25th and the 75th percentile 
(boxes) and minimum and maximum values (whiskers).[LS19] Data shown are representative of 
XXXX independent experiments. [LS20] P values were determined by a non-parametric 
Mann-Whitney test. 
 
Figure 4 Anthelmintic treatment reduces the frequency of CD4+FoxP3+ T cells in helminth 
infected patients. 
The line graph represent the frequency of CD4+FoxP3+ cells in the CD4+ T cell population, 
measured in PBMCs incubated for 18h without stimulation from Control (n=7), Helminth 
(n=14), LTBI (n=35) and co-infected Helminth-LTBI (n=14) patients incubated for 18h without 
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stimulation. The frequency of CD4+FoxP3+ cells in the CD4+ T cell population in PBMCs was 
measured by XXXX[LS21]. The value plot on the left was obtained from patients on the first visit 
(V1), the value plot on the right was obtained on the follow up visit (V2), either more than 4 
months after visit one, or more than 4 months after anthelmintic treatment. Each line represent 
the variation of expression per individual. Data shown are representative of XXXX independent 
experiments. [LS22]The P values were determined by a non-parametric paired Wilcoxon test.  
 
Figure 5 [LS23]Depletion of CD4+CD25+ T cells reduces CD4+FoxP3+ frequency and increas-
es the frequency of CD4+IFNγIFN-γ+ T cells induced by PPD in helminth infected patients. 
(A) The density plot shows the frequency of FoxP3+ cells in the CD4+ population. The values in 
each density plot represent the frequency of CD4+FoxP3+ within the CD4+ population for each 
condition (no depletion, CD25+ bead depleted, CD25+ fraction). The graph represents the fre-
quency of CD4+IFNγIFN-γ+ cells in PBMCs with no stimulation (light grey bar) or after PPD 
stimulation (black bar) for each cell population. (B) The line graphs represents the pooled varia-
tion without (control) or with CD25 depletion (depleted) for 6 helminth infected patients. Are 
plotted the frequency of CD4+FoxP3+ T cells, the frequency of expression of CD4+IFNγIFN-γ+ 
cells in PBMC unstimulated, and the frequency of CD4+IFNγIFN-γ+ cells in PBMC after PPD 
stimulation. P values were determined by a non-parametric Mann-Whitney test. Data shown are 
representative of XXXX independent experiments. [LS24] 
 
Figure 6 [LS25]Measurement of IFNγIFN-γ by Luminex bead array in supernatants from 
fresh blood after 5 days stimulation with PPD or ESAT-6/CFP10. 
The box plots represent the concentration of IFNγIFN-γ in pg per ml, measured in supernatants 
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from blood diluted, after 5 days of stimulation with either PPD (A), or ESAT6/CFP10 (B). Are 
represented the concentration measured from Control (n=21), Helminth (n=53), LTBI (n=38) and 
co-infected Helminth-LTBI (n=34) patients. The white bars represent the concentrations of 
IFNγIFN-γ measured after blood stimulation before treatment (V1), the grey bars represent con-
centrations measured after blood stimulation of the patient’s blood after anthelmintic treatment 
or at follow up (V2). The P values were determined by a non-parametric paired Wilcoxon test. 
Data shown are representative of XXXX independent experiments. [LS26] 
